FAIR USE NOTICE

FAIR USE NOTICE: The information and materials used on this blog, i.e. articles, videos,etc., may contain copyrighted (© ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available to advance understanding of ecological, political, human rights, economic, democracy, scientific, moral, ethical, and social justice issues, spiritual, religious, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior general interest in receiving similar information for research and educational purposes. For more information go to: /http://www.law.cornell.edu/uscode

Thursday, September 30, 2021

The Zelenko Protocol for early Covid Treatment and for Prophylaxis

 

 FROM DR ZELENKO TO PTESIDENT TRUMP in a letter dated April 7th, 2020

My field-tested treatment regimen for high risk patients with clinical diagnosis is as follows:

Hydroxychloroquine 200mg twice a day for 5 days

Azithromycin 500mg once a day for 5 days

Zinc sulfate 220mg (or the equivalent of 50mg elemental zinc) once a day for 5 days

I also suggest the following prophylactic regimen for very high risk individuals:

Hydroxychloroquine 200mg once a day for 5 days, and then 1 pill a week until immunity can be shown or a vaccine becomes available.

Zinc Sulfate 220mg (or the equivalent of 50mg elemental zinc) once a day for 5 days, and then 1 pill a week until immunity can be shown or a vaccine becomes available.

--------------------------------------------------------------------------------------------------------------------------------------------------------------

https://faculty.utrgv.edu/eleftherios.gkioulekas/zelenko/Zelenko-memo-August-prophylaxis.pdf

 

Zelenko Covid-19 Prophylaxis Protocol 

Website: Vladimirzelenkomd.com 

Prophylaxis is an action taken to prevent or protect against a specified disease. Greek in origin, from the word "phylax", meaning "to guard" and "watching." 

Low Risk Patients 

Young healthy people do not need prophylaxis against Covid 19. In young and healthy people, this infection causes mild cold-like symptoms. It is advantageous for these patients to be exposed to Covid-19, build up their antibodies and have their immune system clear the virus. This will facilitate the development of herd immunity and help prevent future Covid-19 pandemics. However, if these patients desire prophylaxis against Covid-19, then they should take the protocol noted below. 

Moderate Risk Patients 

Patients from this category are healthy but have high potential viral-load exposure. This group includes medical personnel, caregivers of high-risk patients, people who use public transportation, first responders and other essential personnel who are crucial to the continued functioning of society. These patients should be encouraged to take prophylaxis against Covid-19 in accordance with the protocol noted below. 

High Risk Patients 

Patients are considered high risk if they are over the age of 45, or if they are younger than 45 but they have comorbidities, that is, they have other health conditions that put them at risk. These patients have between a 5 to 10% mortality rate if they are infected with Covid-19. These patients should be strongly encouraged to take prophylaxis against Covid-19 in accordance with the protocol noted below.

 

Protocol for Low and Moderate Risk Patients: 

Elemental Zinc 25mg 1 time a day 1 

Vitamin D3 5000iu 1 time a day 

Vitamin C 1000mg 1 time a day 2 

Quercetin 500mg 1 time a day until a safe and efficacious vaccine becomes available 

If Quercetin is unavailable, then use Epigallocatechin-gallate (EGCG) 400mg 1 time a day 3


Protocol for High Risk Patients: 

Elemental Zinc 25mg once a day 

Vitamin D3 5000iu 1 time a day 

Hydroxychloroquine (HCQ4 ) 200mg 1 time a day for 5 days, then 1 time a week until a safe and efficacious vaccine becomes available 

If HCQ is unavailable, then use the Protocol for Low and Moderate Risk Patients. 

----------------------------------------------------------------------------------------------------------------------------------------------------------

1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/

2 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/ 

3 https://pubs.acs.org/doi/10.1021/jf5014633 

4 https://www.preprints.org/manuscript/202007.0025/v1

No comments:

Post a Comment